A wave of new drug introductions and healthcare policy changes has had a significant impact on women’s health care over the past year.
Nearly three-quarters of osteoporosis patients prefer to take their medication in a form other than an oral solid, according to a new survey.
Mission Pharmacal has launched what it called an alternative to pill therapy for osteoporosis.
A U.S. drug maker has made a deal with a Swiss company to manufacture and sell a new osteoporosis treatment in North America.
The Food and Drug Administration approved an effervescent tablet for treating osteoporosis.
Analysis by the Food and Drug Administration has yet to establish a link between thigh-bone...